842 related articles for article (PubMed ID: 20091490)
1. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction.
Mitsnefes M; Kartal J; Khoury P; Daniels S
Clin J Am Soc Nephrol; 2007 Jan; 2(1):46-50. PubMed ID: 17699386
[TBL] [Abstract][Full Text] [Related]
3. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
Guebre-Egziabher F; Bernhard J; Funahashi T; Hadj-Aissa A; Fouque D
Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
[TBL] [Abstract][Full Text] [Related]
5. [Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study].
Barrios V; Gómez-Huelgas R; Rodríguez R; de Pablos-Velasco P
Rev Esp Cardiol; 2008 Nov; 61(11):1159-67. PubMed ID: 19000491
[TBL] [Abstract][Full Text] [Related]
6. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
[TBL] [Abstract][Full Text] [Related]
7. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
8. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
White SL; Polkinghorne KR; Atkins RC; Chadban SJ
Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
[TBL] [Abstract][Full Text] [Related]
10. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.
Becker B; Kronenberg F; Kielstein JT; Haller H; Morath C; Ritz E; Fliser D;
J Am Soc Nephrol; 2005 Apr; 16(4):1091-8. PubMed ID: 15743998
[TBL] [Abstract][Full Text] [Related]
11. Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease.
Sengstock D; Sands RL; Gillespie BW; Zhang X; Kiser M; Eisele G; Vaitkevicius P; Kuhlmann M; Levin NW; Hinderliter A; Rajagopalan S; Saran R
Nephrol Dial Transplant; 2010 Mar; 25(3):853-61. PubMed ID: 19854848
[TBL] [Abstract][Full Text] [Related]
12. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
[TBL] [Abstract][Full Text] [Related]
13. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients.
van Ree RM; de Vries AP; Oterdoom LH; The TH; Gansevoort RT; Homan van der Heide JJ; van Son WJ; Ploeg RJ; de Jong PE; Gans RO; Bakker SJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2524-31. PubMed ID: 16115856
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
15. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
[TBL] [Abstract][Full Text] [Related]
17. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
Bayés B; Granada ML; Lauzurica R; Pastor MC; Navarro M; Bonet J; Llopis MA; Romero R
Transplant Proc; 2005 Nov; 37(9):3808-12. PubMed ID: 16386546
[TBL] [Abstract][Full Text] [Related]
18. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
[TBL] [Abstract][Full Text] [Related]
19. Normal adiponectin levels in kidney transplant patients with hypertension.
Leibowitz A; Peleg E; Ben-David A; Sharabi Y; Kamari Y; Holzman E; Grossman E
Clin Transplant; 2013; 27(4):562-6. PubMed ID: 23758483
[TBL] [Abstract][Full Text] [Related]
20. The correlation of renal allograft weight to metabolic index ratios and glomerular filtration rate among living-unrelated kidney transplant patients: a cross-sectional study.
Amante AJ; Piñon-Barretto SC
Transplant Proc; 2008 Sep; 40(7):2313-8. PubMed ID: 18790222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
